EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder

Wenqin Luo, Xiaofei Wang, Lingyao Kong, Hongxi Chen, Ziyan Shi, Hongyu Zhou iD

Annals of Clinical and Translational Neurology · 2023

DOI: 10.1002/acn3.51857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2023. Verfasst von Wenqin Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan Province, PR China. Hauptthemen laut MEDLINE: Neuromyelitis Optica. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Sichuan Province, Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the correlation among body mass index at onset, clinical features, and prognosis in patients with neuromyelitis optica spectrum disorder.

Method

This retrospective cohort studied patients with neuromyelitis optica spectrum disorder from January 2015 to January 2022, grouping them by body mass index at onset. Demographics and clinical records were reviewed. Anderson–Gill, Kaplan–Meier, and Cox models evaluated the body mass index's effect on relapse risk and long‐term outcomes.

Results

Of 246 patients with 799 neuromyelitis optica spectrum disorder attacks study, 36 patients had low, 133 had normal, 77 had high body mass index, with a mean onset age of 40 ± 13 years, and the population was 88% female. The medium follow‐up time was 49 months; AQP4‐IgG was found in 193 (78%) patients. Onset and relapse of area postrema syndrome were less frequent in patients with a normal body mass index. The annual relapse rate after immunosuppressive therapy was significantly lower in patients with a low body mass index. In the multivariable analysis, statistical correlation still existed between body mass index at onset and risk of relapse (HR = 1.03, 95% CI: 1.03–1.03, P < 0.001), risk of severe attack (HR = 0.92, 95% CI: 0.86–0.98, P = 0.013), risk of visual disability (HR = 0.9, 95% CI: 0.81–1, P = 0.047), and overall risk of disability (HR = 0.89, 95% CI: 0.82–0.98, P = 0.015) after adjusting various variables.

Interpretation

Lower body mass index at onset was associated with less frequent relapse but poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaHumansFemaleAdultMiddle AgedMaleBody Mass IndexRetrospective StudiesAquaporin 4PrognosisRecurrence

Substanzen

Aquaporin 4

Autor:innen und Institutionen

  • Department of Neurology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan Province, PR China.

ORCID-Profile: Hongyu Zhou

Förderung

  • Natural Science Foundation of Sichuan Province
  • Department of Science and Technology of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Luo, W., Wang, X., Kong, L., Chen, H., Shi, Z., & Zhou, H. (2023). Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51857

Vancouver

Luo W, Wang X, Kong L, Chen H, Shi Z, Zhou H. Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder. Annals of Clinical and Translational Neurology. 2023. doi:10.1002/acn3.51857

BibTeX
@article{Luo2023,
  author = {Luo, Wenqin and Wang, Xiaofei and Kong, Lingyao and Chen, Hongxi and Shi, Ziyan and Zhou, Hongyu},
  title = {Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  doi = {10.1002/acn3.51857}
}
Kostenlos starten →